James Clifford Perry, MD
Pediatric Cardiology · Palo Alto
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Perry’s office at (650) 497-8000 to ask if they take your plan before you enroll.
California Medical Board record
Licence G76012 · Current
Licensed to practise in California · since 1993 · expires 2029-01-31 · University of Rochester School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Adult Congenital Heart Disease
Medicaid work
$9,975 in 2023
Medicaid paid $9,975 for 1,065 billed services this clinician did in 2023, up to 139 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,013 | $8,640 |
| XTRNL ECG REC<48 HR R&I | 52 | $1,335 |
| 2023 | 1,065 | 2 | 139 | $9,975 |
| 2022 | 2,508 | 3 | 166 | $21,657 |
| 2021 | 3,579 | 3 | 334 | $35,939 |
| 2020 | 2,968 | 4 | 212 | $31,733 |
| 2019 | 3,180 | 5 | 215 | $35,703 |
| 2018 | 2,839 | 4 | 191 | $33,513 |
See the largest Medicaid services in earlier years
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2,319 | $16,980 |
| XTRNL ECG REC<48 HR R&I | 176 | $4,235 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 13 | $441 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 3,191 | $25,666 |
| XTRNL ECG REC<48 HR R&I | 346 | $8,555 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 42 | $1,717 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2,612 | $22,419 |
| XTRNL ECG REC<48 HR R&I | 326 | $8,276 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 15 | $527 |
| Service | 15 | $512 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2,681 | $23,118 |
| XTRNL ECG REC<48 HR R&I | 354 | $8,749 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 90 | $2,167 |
| Service | 37 | $1,262 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 18 | $407 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2,353 | $20,377 |
| XTRNL ECG REC<48 HR R&I | 361 | $8,979 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 105 | $2,613 |
| Return visit (30+ min) | 20 | $1,543 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 11 Part D prescriptions in 2022. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2022 | 11 | None | 0% (0) | 0% | $296 |
| 2019 | 14 | None | 0% (0) | None | $428 |
| 2018 | 12 | None | 0% (0) | None | $610 |
| 2016 | 16 | None | 0% (0) | 81% | $37,394 |
| 2015 | 38 | None | 0% (0) | 53% | $29,967 |
| 2014 | 50 | None | None | 48% | $24,502 |
| 2013 | 33 | None | 0% (0) | 39% | $20,385 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2016: 1 drug
| Adcirca | 13 | $37,291 | $2,869 |
2015: 1 drug
| Adcirca | 12 | $28,944 | $2,412 |
2014: 1 drug
| Adcirca | 11 | $21,808 | $1,983 |
2013: 1 drug
| Adcirca | 12 | $20,046 | $1,671 |
Money from drug and device companies
$22,176 in 2025
| 2025 | 4 | 13 | $21,490 | $22,176 |
| 2024 | 2 | 2 | None | $251 |
| 2023 | 1 | 4 | $2,900 | $2,939 |
| 2022 | 1 | 1 | None | $108 |
| 2021 | 2 | 2 | None | $32 |
| 2019 | 3 | 33 | None | $225 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Philips North America | Mcot | $17,640 | 4 payments
|
| AltaThera Pharmaceuticals | Sotalol Hydrochloride | $4,493 | 2 payments
|
| Vifor Pharma | Zemaira | $25 | 1 payment
|
| Biosense Webster | Carto 3 | $18 | 1 payment
|
See all 8 published payments
| Philips North America | Consulting · 2025-09-23 | Mcot | $5,145 |
| Philips North America | Consulting · 2025-07-22 | Mcot | $5,145 |
| Biosense Webster | Meals · 2025-06-26 | Carto 3 | $18 |
| AltaThera Pharmaceuticals | Consulting · 2025-05-16 | Sotalol Hydrochloride | $3,850 |
| AltaThera Pharmaceuticals | Meals · 2025-04-23 | Sotalol Hydrochloride | $643 |
| Philips North America | Consulting · 2025-04-22 | Mcot | $3,675 |
| Philips North America | Consulting · 2025-03-21 | Mcot | $3,675 |
| Vifor Pharma | Meals · 2025-03-04 | Zemaira | $25 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $251
| AltaThera Pharmaceuticals | Sotalol Hydrochloride | $168 | 1 payment
|
| Biosense Webster | Carto 3 | $83 | 1 payment
|
2023: $2,939
| AltaThera Pharmaceuticals | Sotalol Hydrochloride | $2,939 | 2 payments
|
2022: $108
| Philips Electronics North America | (5050) Ext Holter | $108 | 1 payment
|
2021: $32
| Biosense Webster | Carto 3 | $18 | 1 payment
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $14 | 1 payment
|
2019: $225
| Medtronic Vascular | Azure | $143 | 3 payments
|
| AltaThera Pharmaceuticals | Sotalol Hydrochloride | $68 | 1 payment
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $15 | 1 payment
|
Professional record
- NPI
- 1861474561
- Licence
- CA G76012California G76012: Current · expires 2029-01-31
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2080P0202X (2080P0202X); Federal specialty code 207RA0002X (207RA0002X); Pediatrics (208000000X)
- Mailing address
- 725 Welch Rd, Palo Alto, CA, 94304
- NPI first listed
- 2005-11-17
- NPI last updated
- 2024-04-12
- NPI record certified
- 2024-04-12
This is when the NPI record was last certified, not a medical board exam.